We set out to develop Simoa aggregate assays todetect protein aggregates relevant to neurodegenerative diseases,including native and C-terminal truncated α-synuclein (α-syn),β-amyloid (Aβ), tau, and phosphorylated tau (p-tau). The gene discussed is MAPT; the disease is neurodegenerative disease.